Pharmacovigilance Analysis of Serious Adverse Events Reported for Biologic Response Modifiers Used as Prophylaxis against Transplant Rejection: a Real-World Postmarketing Experience from the US FDA Adverse Event Reporting System (FAERS)

Pharmacovigilance Analysis of Serious Adverse Events Reported for Biologic Response Modifiers Used as Prophylaxis against Transplant Rejection: a Real-World Postmarketing Experience from the US FDA Adverse Event Reporting System (FAERS)

Background: Immunosuppression by biologic response modifiers (BRM) is a crucial component for successfulorgan transplantation. In addition to their variable effectiveness in the prevention of organ rejection,these medications have safety concerns that complicate therapeutic outcomes in organ transpl...

Full description

Bibliographic Details
Main Author: A. K. Ali
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2013-04-01
Series:International Journal of Organ Transplantation Medicine
Subjects:
Immunosuppressive medications
Biologic response modifiers
Pharmacovigilance
Serious adverse events
FAERS
Online Access:http://home.sums.ac.ir/~habibzaf/ojs/index.php/IJOTM/article/view/148/276

Internet

http://home.sums.ac.ir/~habibzaf/ojs/index.php/IJOTM/article/view/148/276

Similar Items